Table 3Characteristics of Included Randomized Controlled Trials

Study citation, country, funding Study design Population

characteristics

Intervention and comparators Relevant outcomes, length of follow up, opioids provided
Aksoy et al. (2023)15

Turkey

Funding: Study authors did not receive financial support or funding.

Double-blind, 3-arm RCT with 2 arms relevant for this report.

Single centre.

Participants randomized in a 1:1:1 ratio via a computer-aided random number chart.

Singleton pregnant womena who had been scheduled for elective Caesarean delivery.

N, randomized = 105

IV paracetamol, n = 35

Placebo, n = 35

Age (years), mean(SD)

IV paracetamol = 26.69(6.45)

Placebo = 29.51(5.38)

Intervention: IV paracetamol 1 g in 100 mL for infusion

Comparator: Placebo (subcutaneous 20 mL and IV saline)

All participants received their intervention after Caesarean delivery and after every 6 hours for 24 hours.

Outcome: Total morphine consumption

Length of follow up: NR

Opioids: Morphine through PCA

Westrich et al. (2019)14

US

Funding source: Mallinckrodt Pharmaceuticals and the Hospital for Special Surgery, Research and Education Fund.

Double-blind, 2-arm RCT,

Single centre.

Participants randomized in a 1:1 ratio block of size 6 and 8 via a computer generated randomization schedule.

Individuals aged 18 to 90 years old scheduled for an elective primary unilateral total hip arthroplasty using a posterior approach.

N, randomized = 154

IV acetaminophen, n = 77

Oral acetaminophen, n = 77

Age (years), median (SD)

IV acetaminophen = 63(10)

Oral acetaminophen = 65(10)

Sex (male %)

IV acetaminophen = 36.4%

Oral acetaminophen = 45.5%

Pain at rest, numerical rating scale, mean (SD)

IV acetaminophen = 3.9(2.6)

Oral acetaminophen = 4.2(2.6)

Pain at ambulation, numerical rating scale, mean (SD)

IV acetaminophen = 6.5(2.5)

Oral acetaminophen = 6.7(2.4)

Intervention:

15 minute infusion of 1g of IV acetaminophen (Ofirmev) in a 100 mL solution with oral placebo (2 capsules)

Comparator: Oral acetaminophen (1 g in 2 capsules) with IV placebo (100 mL saline)

All study arms received their assignment 30 minutes after admission to postanesthesia care unit.

Outcome and length of follow up: Cumulative opioid usage between postoperative day 0 and day 3 (measured as opioid consumption in mg of oral morphine equivalent)

Opioids: 50 mg of tramadol for mild pan, 100 mg of tramadol for moderate pain, 5 mg of oxycodone for severe pain, 10/15 mg of oxycodone as needed.

NR = not reported; PCA = patient-controlled analgesia; RCT = randomized controlled trial; SD = standard deviation.

a

The study described their study population as women and did not differentiate between sex and gender. We acknowledge that gender is a spectrum, and such language is not inclusive of trans and nonbinary persons. When the term “women” was used in the study we retained the term in our reporting on these studies.

From: Opioid-Sparing Effects of IV Acetaminophen for Patients Undergoing Surgery

Cover of Opioid-Sparing Effects of IV Acetaminophen for Patients Undergoing Surgery
Opioid-Sparing Effects of IV Acetaminophen for Patients Undergoing Surgery: Rapid Review [Internet].
Santos C, Lachance CC, Bailey S; Authors.
Copyright Notice

Copyright © 2024 - Canadian Agency for Drugs and Technologies in Health. Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND).

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.